Trade Bristol Myers BMY

Sell
 Buy

BristolMyers live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

Liam James 2025 Oct 31, 00:00

Fed Rate Decision: Uncertainty Looms Amid Data Lacks, Divisions

Noah Lee 2025 Oct 31, 00:00

Gold Price Outlook 2024: Natixis Analysis Warns of Further Downside

Emma Rose 2025 Oct 31, 00:00

US Government Shutdown: An Analysis of Causes and Potential Resolutions

Frances Wang 2025 Oct 30, 16:00

Gold price forecast: gold falls to $4,002, will XAU/USD continue to drop?

Frances Wang 2025 Oct 30, 16:00

Stock trend analysis: stocks to watch today, AMZN stock, Qualcomm stock

stocks
Frances Wang 2025 Oct 30, 16:00

MicroStrategy stock analysis: MSTR dropped 7% today, what’s next?

Frances Wang 2025 Oct 30, 16:00

Bitcoin Price (BTC/USD) Analysis: Can BTC Hit $125K in November?

Frances Wang 2025 Oct 30, 16:00

NAVN stock dropped 20% today: What happened to Navan Inc?

Frances Wang 2025 Oct 29, 16:00

NVDA Stock Jumps over 2.99%: Why Nvidia (NVDA) Stock Is Rising Today?

Frances Wang 2025 Oct 29, 16:00

Oil price forecast: Crude oil dropped, how does OPEC affect oil prices?

Latest news

Show more
Sophia Claire 2025 Oct 31, 20:10

Stablecoin Infrastructure, Bitcoin Mining, and Digital Lending Updates

Noah Lee 2025 Oct 31, 19:20

US Court Denies Custodia Bank's Appeal for Federal Reserve Master Account

Sophia Claire 2025 Oct 31, 19:10

Crypto Market Update: Saylor's Bitcoin Outlook, ETF Flows, and DeFi Insights

Emma Rose 2025 Oct 31, 18:50

ETF-Driven Capital Concentrates in Mature Cryptocurrencies: A Market Shift

Ava Grace 2025 Oct 31, 17:30

US Treasury Chief Hails Singapore's Stablecoin & Digital Asset Leadership

Sophia Claire 2025 Oct 31, 16:50

Stablecoin Fragmentation: Challenges and Future Solutions

Emma Rose 2025 Oct 31, 16:40

Coinbase Policy Chief Responds to Criticism Over Trump Administration Ties

Ava Grace 2025 Oct 31, 14:20

Basel Committee Revisits Crypto Guidance: A More Favorable View for Banks?

Info

Spread

0.29

Spread (%)

0.6314 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

92856573952

Shares Outstanding

2035435838

Earnings Date (Next)

2001-08-07

Div Yield

2025-11-03

Ex-Dividend Date

2025-10-03

Forward annual dividend rate

2.48

Forward annual dividend yield

0.0582

EPS

2.49

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Oct 30, 16:00

Stock CFD trading basics: How to start trading stocks as a beginner?

Ghko B 2025 Oct 30, 16:00

Bitcoin price near $109K today: How much will $1 Bitcoin be worth in 2030?

Ghko B 2025 Oct 30, 16:00

Day trading basics: What is the best method for day trading?

Trustpilot